VULVAR NEOPLASMS
Clinical trials for VULVAR NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new VULVAR NEOPLASMS trials appear
Sign up with your email to follow new studies for VULVAR NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: VULVAR NEOPLASMS
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Blood test and survey combo could spot vulva cancer return earlier
Knowledge-focused Recruiting nowThis study looks at whether regular patient questionnaires and a special blood test (circulating tumor DNA) can detect vulva cancer recurrence earlier than standard follow-up. About 295 women with vulva cancer will be followed for two years, and their results will be compared to …
Matched conditions: VULVAR NEOPLASMS
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC